MAFLD and Cardiovascular Events: What Does the Evidence Show?
Clin Gastroenterol Hepatol
.
2021 Oct;19(10):2025-2028.
doi: 10.1016/j.cgh.2021.02.027.
Epub 2021 Feb 18.
Authors
Jacob George
1
,
Robert G Gish
2
,
Andreas Geier
3
Affiliations
1
Storr Liver Centre, The Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, New South Wales, Australia.
2
Division of Gastroenterology and Hepatology, Loma Linda University, Loma Linda, California.
3
Division of Hepatology, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
PMID:
33610759
DOI:
10.1016/j.cgh.2021.02.027
No abstract available
Publication types
Editorial
Comment
MeSH terms
Cardiovascular Diseases* / epidemiology
Humans
Non-alcoholic Fatty Liver Disease*
Risk Factors